| Literature DB >> 22039914 |
Dragic Vukomanovic1, Brian E McLaughlin1, Mona N Rahman2, Walter A Szarek3, James F Brien1, Zongchao Jia2, Kanji Nakatsu1.
Abstract
While substantial progress has been made in elucidating the roles of heme oxygenases-1 (HO-1) and -2 (HO-2) in mammals, our understanding of the functions of these enzymes in health and disease is still incomplete. A significant amount of our knowledge has been garnered through the use of nonselective inhibitors of HOs, and our laboratory has recently described more selective inhibitors for HO-1. In addition, our appreciation of HO-1 has benefitted from the availability of tools for increasing its activity through enzyme induction. By comparison, there is a paucity of information about HO-2 activation, with only a few reports appearing in the literature. This communication describes our observations of the up to 30-fold increase in the in-vitro activation of HO-2 by menadione. This activation was due to an increase in Vmax and was selective, in that menadione did not increase HO-1 activity.Entities:
Keywords: activateur; activator; brain; cerveau; constitutive heme oxygenase; heme oxygenase-2; hème oxygénase constitutive; hème oxygénase recombinante tronquée humaine; hème oxygénase-2; recombinant truncated human heme oxygenase; selectivity; sélectivité
Mesh:
Substances:
Year: 2011 PMID: 22039914 DOI: 10.1139/y11-091
Source DB: PubMed Journal: Can J Physiol Pharmacol ISSN: 0008-4212 Impact factor: 2.273